Taiwanese Pharmaceuticals & Biotech High And Sustainable

Results

1 new

Companies in a sound financial shape with a dividend yield of more than 5%.

5 companies

TSH Biopharm

Market Cap: NT$1.9b

Develops and markets pharmaceutical products in Taiwan.

8432

NT$50.50

-0.6%

7.9%

Allied Biotech

Market Cap: NT$2.3b

Engages in the manufacture and sale of carotenoids worldwide.

1780

NT$23.75

4.4%

36.9%

TTY Biopharm

Market Cap: NT$18.9b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.

4105

NT$76.10

-0.5%

-0.4%

Bioray Biotech

Market Cap: NT$505.9m

Engages in the research, development, production, and sells health foods, immune cell products, and precision testing services in Taiwan.

7561

NT$17.10

-37.9%

SYN-TECH Chem. & Pharm

Market Cap: NT$3.3b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.

1777

NT$74.50

-0.4%

1.2%